Nasal application of a naturally processed and presented T cell epitope derived from TCR AV11 protects against adjuvant arthritis

International Immunology

Volumn 12, Issue 12, 2000, Pages 1715-1721

  van Tienhoven, E A E ^a   Broeren, C P M ^a   Noordzij, A ^a   Wagenaar, J P A ^a   van Eden, W ^a   Wauben, M H M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Autoimmunity; Suppression; T lymphocytes; TCR

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR AV11 PEPTIDE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFECT; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN DOMAIN; PROTEIN PROCESSING; RAT; T LYMPHOCYTE;

EID: 0034533498     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.12.1715     Document Type: Article

References (41)

1. Do heat shock proteins control the balance of T cell regulation in inflammatory diseases?
2. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis
3. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis
4. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis
5. + T-cells in recovery from antigen-induced autoimmune disease
6. Natural immunodominant and experimental autoimmune encephalomyelitis-protective determinants within the Lewis rat V.beta 8.2 sequence include CDR2 and framework 3 idiotopes
7. Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide
8. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis
9. Immunization with T cell receptor Vb chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice
10. β8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis
11. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention
12. Characterization of the T-cell receptor repertoire causing collagen arthritis in mice
13. CDR1 T-cell receptor β-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions
14. T-cell receptor vbeta deletion and valpha polymorphism are responsible for the resistance of SWR mouse to arthritis induction
15. α domain of a TCR prevents the development of collagen-induced arthritis
16. Heat shock protein T-cell epitopes as immunogenic carriers in subunit vaccines
17. Autoimmunity to type II collagen an experimental model of arthritis
18. Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules
19. Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes
20. Mechanisms underlying T-cell tolerance
21. Persisting viruses and chronic inflammation: Understanding their relation to autoimmunity
22. Determinant spreading during experimental autoimmune encephalomyelitis: Is it potentiating, protecting or participating in the disease?
23. Activated rat T cells synthesize and express functional major histocompatibility class II antigens
24. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
25. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis
26. h2 responses and prevents murine insulin-dependent diabetes
27. Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein
28. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: Identification of regulatory cells
29. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE)
30. Neonatal exposure of TCR BV8S2 transgenic mice to recombinant TCR BV8S2 results in reduced T cell proliferation and elevated antibody response to BV8S2, and increased severity of EAE
31. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells
32. Induction of experimental autoimmune arthritis by a public epitope of the T cell receptor variable α domain of an arthritogenic T cell clone
33. T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis
34. Pretreatment with T cell receptor peptides using conventional immunization protocol does not induce effective protection against autoimmune encephamyelitis
35. An alpha-chain TCR CDR3 peptide can enhance EAE induced by myelin basic protein or proteolipid protein
36. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE)
37. Neonatal exposure of TCR BV8S2 transgenic mice to recombinant TCR BV8S2 results in reduced T cell proliferation and elevated antibody response to BV8S2, and increased severity of EAE
38. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells
39. h2 immunity
40. Regulation of NOD mouse diabetes by T cells that recognize a TCR CDR3 peptide